¿pueden las enfermedades médicas causar depresión?

¿Pueden las enfermedades médicas causar depresión?

Kanner AM. Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment. Biol Psychiatry. 2003;54(3):388-398. Lambert MV, Robertson MM. Depression in epilepsy: etiology, phenomenology, and treatment. Epilepsia. 1999;40(suppl 10): S21-S47. Patten SB, Neutel CI. Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and management. Drug Saf. 2000;22(2):111-122. Asnis GM, De La Garza R 2nd. Interferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology and treatment approaches. J Clin Gastroenterol. 2006;40(4):322-335. Goeb JL, Even C, Nicolas G, et al. Psychiatric side effects of interferon-beta in multiple sclerosis. Eur Psychiatry. 2006;21(3):186-193. Hull PR, D’Arcy C. Isotretinoin use and subsequent depression and suicide: presenting the evidence. Am J Clin Dermatol. 2003;4(7):493-505. U.S. Food and Drug Administration. Information for Healthcare Professionals: Varenicline (marketed as Chantix) and Bupropion (marketed as Zyban, Wellbutrin, and generics). Drug SafetyIn formation for Heath care Professionals/ ucm169986.htm. Accessed July 7, 2009. Larisch R, Kley K, Nikolaus S, et al. Depression and anxiety in different thyroid function states. Horm Metab Res. 2004;36(9):650-653. Pop VJ, Maartens LH, Leusink G, et al. Are autoimmune thyroid dysfunction and depression related? J Clin Endocrinol Metab. 1998;83(9):3194-3197. Gold MS, Pottash AL, Extein I. Hypothyroidism and depression. Evidence from complete thyroid function evaluation. JAMA. 1981;245(19):1919-1922. Joffe RT, Singer W, Levitt AJ, et al. A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression. Arch Gen Psychiatry. 1993;50(5):387-393. Wilhelm SM, Lee J, Prinz RA. Major depression due to primary hyperparathyroidism: a frequent and correctable disorder. Am Surg. 2004;70(2):175-179. Sonino N, Fava GA. Psychiatric disorders associated with Cushing’s syndrome. Epidemiology, pathophysiology, and treatment. CNS Drugs. 2001;15(5):361-373. Sonino N, Fava GA, Raffi AR, et al. Clinical correlates of major depression in Cushing’s disease. Psychopathology. 1998;31(6):302-306. Dorn LD, Burgess ES, Dubbert B, et al. Psychopathology in patients with endogenous Cushing’s syndrome: ‘atypical’ or melancholic features. Clin Endocrinol (Oxf). 1995;43(4):433-442. Zeiger MA, Fraker DL, Pass HI, et al. Effective reversibility of the signs and symptoms of hypercortisolemia by bilateral adrenalectomy. Surgery. 1993;114(6):1138-1143. Thomsen AF, Kvist TK, Andersen PK, et al. The risk of affective disorders in patients with adrenocortical insuffi ciency. Psychoneuroendocrinology. 2006;31(5):614-622. Gainotti G, Azzoni A, Marra C. Frequency, phenomenology and anatomical-clinical correlates of major post-stroke depression. Br J Psychiatry. 1999;175:163-167. Newberg AR, Davydow DS, Lee HB. Cerebrovascular disease basis of depression: post-stroke depression and vascular depression. Int Rev Psychiatry. 2006;18(5):433-441. Hughes J, Devinsky O, Flemann E, et al. Premonitory symptoms in epilepsy. Seizure. 1993;2(3):201 203. Shoenfeld M, Myers RH, Cupples RA, et al. Increased rate of suicide among patients with Huntington’s disease. J Neurol Neurosurg Psychiatry. 1984;47(12):1283-1287. Tost H, Wendt CS, Schmitt A, et al. Huntington’s disease: phenomenological diversity of a neuropsychiatric condition that challenges traditional concepts in neurology and psychiatry. Am J Psychiatry. 2004;161(1):28-34. Rosenblatt A. Neuropsychiatry of Huntington’s disease. Dialogues Clin Neurosci. 2007;9(2):191-197. Paulsen JS, Ready RE, Hamilton JM, et al. Neuropsychiatric aspects of Huntington’s disease. J Neurol Neurosurg Psychiatry. 2001;71(3):310-314. Anderson KE. Huntington’s disease and related disorders. Psychiatry Clin North Am. 2005;28(1):275 290. Loudianos G, Gitlin JD. Wilson’s disease. Semin Liver Dis. 2000;20(3):353-364. Chwastiak L, Ehde DM, Gibbons LE, et al. Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. Am J Psychiatry. 2002;159(11):1862-1868. Feinstein A. The neuropsychiatry of multiple sclerosis. Can J Psychiatry. 2004;49(3):157-163. Siegert RJ, Abernethy DA. Depression in multiple sclerosis: a review. J Neurol Neurosurg Psychiatry. 2005;76(4):469-475. Feinstein A, Roy P, Lobaugh N, et al. Structural brain abnormalities in multiple sclerosis patients with major depression. Neurology. 2004;62(4):586-590. McDonald WM, Richard IH, DeLong MR. Prevalence, etiology and treatment of depression in Parkinson’s disease. Biol Psychiatry. 2003;54(3):363-375. Lyketsos CG, Kozauer N, Rabins PV. Psychiatric manifestations of neurologic disease: where are we headed? Dialogues Clin Neurosci. 2007;9(2):111-124. Rosenblatt A, Leroi I. Neuropsychiatry of Huntington’s disease and other basal ganglia disorders. Psychosomatics. 2000;41(1):24-30. Penzak SR, Reddy YS, Grimsley SR. Depression in patients with HIV infection. Am J Health Syst Pharm. 2000;57(4):376-386. Basu S, Chwastiak LA, Bruce RD. Clinical management of depression and anxiety in HIV-infected adults. AIDS. 2005;19(18):2057-2067. Gibbie T, Mijch A, Ellen S, et al. Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year followup. HIV Med. 2006;7(2):112-121. Ammassari A, Antinori A, Aloisi MS, et al. Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychosomatics. 2004;45(5):394-402. Murray KO, Resnick M, Miller V. Depression after infection with West Nile virus. Emerg Infect Dis. 2007;13(3):479-481. Elkins LE, Pollina DA, Scheffer SR, et al. Psychological states and neuropsychological performances in chronic Lyme disease. Appl Neuropsychol. 1999;6(1):19-26. Sanchez FM, Zisselman MH. Treatment of psychiatric symptoms associated with neurosyphilis. Psychosomatics. 2007;48(5):440-445. Carta MG, Hardoy MC, Garofalo A, et al. Association of chronic hepatitis C with major depressive disorders: irrespective of interferon-alpha therapy. Clin Pract Epidemol Ment Health. 2007;3:22. Wessely S, Pariante C. Fatigue, depression and chronic hepatitis C infection. Psychol Med. 2002;32(1):1-10. Dieperink E, Ho SB, Thuras P. A prospective study of neuropsychiatry symptoms associated with interferon-alpha- 2b and ribavirin therapy for patients with chronic hepatitis C. Psychosomatics. 2003;44(2):104-112. Carney CP, Jones L, Woolson RF, et al. Relationship between depression and pancreatic cancer in the general population. Psychosom Med. 2003;65(5):884-888. Farrugia ME, Conway R, Simpson DJ, et al. Paraneoplastic limbic encephalitis. Clin Neurol Neurosurg. 2005;107(2):128-131. Gultekin SH, Rosenfeld MR, Voltz R, et al. Paraneoplastic limbic encephalitis: neurological symptoms, immunological fi ndings, and tumor association in 50 patients. Brain. 2000;123(pt 7):1481-1494.

Source: http://www.intramed.net/userfiles/file/%C3%82%C2%BFPueden%20las%20enfermedades%20m%C3%83%C2%A9dicas%20causar%20depresi%C3%83%C2%B3n_.pdf

Jcn500849 1.6

Prevalence of Sleep Disturbances in Children With Neurofibromatosis Type 1 Amy K. Licis, Alicia Vallorani, Feng Gao, Cynthia Chen, Jason Lenox, Kelvin A. Yamada, Stephen P. Duntley andThe online version of this article can be found at: can be found at: Journal of Child Neurology Additional services and information for ª The Author(s) 2013Reprints and permission:Amy K. Licis, M

Microsoft powerpoint - 08benny.ppt [compatibility mode]

Stable Free Radical Assisted Peroxide Vulcanisation: Cure characteristics and vulcanisate properties Benny George and Rosamma Alex Rubber Technology Division Advanced Center For Rubber Technology Rubber Research Institute of India Kottayam, Kerala, India. IRC & IRRDB Meeting, 29 October to 2 November 20012, Kovalam, Kerala Vulcanisation Viscous raw rubber

Copyright © 2010-2014 Medical Articles